Qualigen Therapeutics, Inc. (QLGN)
Largest Insider Buys in Sector
QLGN Stock Price History Chart
QLGN Stock Performance
About Qualigen Therapeutics, Inc.
Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.
Insider Activity of Qualigen Therapeutics, Inc.
Over the last 12 months, insiders at Qualigen Therapeutics, Inc. have bought $0 and sold $0 worth of Qualigen Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Qualigen Therapeutics, Inc. have bought $56,050 and sold $124,085 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 30,000 shares for transaction amount of $17,100 was made by Poirier Michael S. (Chairman and CEO) on 2022‑06‑22.
List of Insider Buy and Sell Transactions, Qualigen Therapeutics, Inc.
| 2022-06-22 | Poirier Michael S. | Chairman and CEO | 30,000 0.0839% | $0.57 | $17,100 | -74.28% | ||
| 2022-06-14 | BROIDRICK AMY S. | President/CSO | 30,000 0.0874% | $0.62 | $18,600 | -74.91% | ||
| 2021-08-19 | Kruger Kurt H | director | 8,000 0.0272% | $1.23 | $9,800 | -41.01% | ||
| 2021-04-26 | BROIDRICK AMY S. | EVP, Chief Strategy Officer | 4,500 0.0141% | $2.03 | $9,135 | -45.98% | ||
| 2021-04-20 | Poirier Michael S. | Chairman, CEO & President | 11,005 0.0379% | $1.80 | $19,809 | -31.49% | ||
| 2021-04-16 | Lotz Christopher L. | Vice President of Finance, CFO | 2,700 0.0096% | $1.86 | $5,022 | -30.77% | ||
| 2020-12-29 | Kruger Kurt H | director | 4,000 0.0138% | $2.94 | $11,740 | -39.37% | ||
| 2020-11-23 | Kruger Kurt H | director | 4,600 0.0169% | $3.46 | $15,925 | -41.62% | ||
| 2020-11-20 | Kruger Kurt H | director | 1,400 0.005% | $3.55 | $4,969 | -44.92% | ||
| 2020-03-12 | Sale | Doyle Noah | director | 500,000 0.1573% | $0.22 | $110,000 | -18.12% | |
| 2020-03-04 | Sale | Ritter Ira E. | COB, CSO | 18,750 0.005% | $0.38 | $7,043 | -58.02% | |
| 2020-03-04 | Sale | Ritter Andrew J | CEO and President | 18,750 0.005% | $0.38 | $7,043 | -58.02% | |
| 2018-08-17 | FOEHR MATTHEW W | director | 19,751 0.0067% | $2.04 | $40,292 | -53.32% | ||
| 2017-10-03 | Javelin Venture Partners, L.P. | 10 percent owner | 5M 0.1754% | $0.40 | $2M | -18.13% | ||
| 2017-10-03 | Doyle Noah | 5M 0.1754% | $0.40 | $2M | -18.13% | |||
| 2017-10-03 | Ritter Ira E. | Exec. Chairman, CSO | 187,500 0.0066% | $0.40 | $75,000 | -18.13% | ||
| 2017-10-03 | Ritter Andrew J | President | 187,500 0.0066% | $0.40 | $75,000 | -18.13% | ||
| 2017-05-18 | FOEHR MATTHEW W | director | 18,000 0.0006% | $0.62 | $11,155 | -45.94% | ||
| 2017-05-11 | Step Michael D | CEO | 13,000 0.0004% | $0.62 | $8,007 | -43.55% | ||
| 2017-02-27 | Step Michael D | CEO | 10,000 0.0003% | $2.65 | $26,480 | -80.14% |
Insider Historical Profitability
| Javelin Venture Partners, L.P. | 10 percent owner | 7047804 136.0301% | $0.17 | 2 | 0 | |
| Doyle Noah | director | 704780 13.603% | $0.17 | 2 | 1 | |
| Poirier Michael S. | Chairman and CEO | 199202 3.8448% | $0.17 | 2 | 0 | <0.0001% |
| Ritter Ira E. | COB, CSO | 81727 1.5774% | $0.17 | 2 | 1 | |
| Ritter Andrew J | CEO and President | 81727 1.5774% | $0.17 | 2 | 1 | |
| Step Michael D | CEO | 50000 0.9651% | $0.17 | 3 | 0 | |
| PROEHL GERALD T | director | 50000 0.9651% | $0.17 | 1 | 0 | |
| BROIDRICK AMY S. | President/CSO | 34500 0.6659% | $0.17 | 2 | 0 | <0.0001% |
| FOEHR MATTHEW W | director | 23251 0.4488% | $0.17 | 4 | 0 | |
| Kruger Kurt H | director | 18000 0.3474% | $0.17 | 4 | 0 | <0.0001% |
| Lotz Christopher L. | Vice President of Finance, CFO | 12541 0.2421% | $0.17 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
No records found… | |||||||